AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 29.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $64,000 | +106.5% | 102,477 | +848.9% | 0.00% | – |
Q1 2018 | $31,000 | -62.7% | 10,800 | -63.6% | 0.00% | – |
Q4 2017 | $83,000 | -49.1% | 29,665 | -68.3% | 0.00% | -100.0% |
Q2 2015 | $163,000 | +17.3% | 93,492 | -2.6% | 0.00% | 0.0% |
Q1 2015 | $139,000 | +120.6% | 95,978 | +177.8% | 0.00% | – |
Q2 2014 | $63,000 | -48.8% | 34,550 | -58.0% | 0.00% | -100.0% |
Q1 2014 | $123,000 | -57.6% | 82,235 | -47.8% | 0.00% | -50.0% |
Q4 2013 | $290,000 | +1060.0% | 157,438 | +1203.3% | 0.00% | – |
Q3 2013 | $25,000 | -37.5% | 12,080 | -25.3% | 0.00% | – |
Q2 2013 | $40,000 | – | 16,180 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,590,673 | $1,399,000 | 1.00% |
Deer VI & Co. LLC | 675,242 | $365,000 | 0.28% |
Sarissa Capital Management LP | 1,700,000 | $917,000 | 0.25% |
NEA Management Company, LLC | 10,362,694 | $5,596,000 | 0.22% |
Perceptive Advisors | 3,108,808 | $1,678,000 | 0.12% |
Cormorant Asset Management, LP | 1,087,715 | $587,000 | 0.08% |
683 Capital Management, LLC | 1,000,000 | $540,000 | 0.04% |
Spark Investment Management LLC | 95,800 | $51,000 | 0.00% |
Elgethun Capital Management | 10,000 | $5,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 14,738 | $8,000 | 0.00% |